Kevin James Finn

Title: Kevin James Finn: Innovator in Oligonucleotide Manufacturing

Introduction

Kevin James Finn is a notable inventor based in Blue Ash, Ohio. He has made significant contributions to the field of oligonucleotide manufacturing. His innovative approach has led to the development of a unique process that enhances the efficiency of producing oligonucleotides.

Latest Patents

Kevin holds a patent for a process for the manufacture of oligonucleotides. This process involves the removal of β-eliminating phosphorus-protecting groups, specifically β-cyanoethyl protective groups, from a protected oligonucleotide. The method includes contacting the protected oligonucleotide with an amine solution in a solvent that preferably does not consist of pyridine. The conjugate acid of the amine has a pKa of greater than 11.5, and the concentration of the amine in the solution is less than 0.5 mole/liters. This innovative process has the potential to streamline oligonucleotide production.

Career Highlights

Kevin is currently employed at Nitto Denko Avecia, Inc., where he continues to advance his research and development efforts. His work has garnered attention in the scientific community, particularly for its practical applications in biotechnology and pharmaceuticals.

Collaborations

Kevin collaborates with esteemed colleagues, including Tadeusz Krzysztof Wyrzykiewicz and Hagen Cramer. These partnerships enhance the research environment and foster innovation within the field.

Conclusion

Kevin James Finn is a prominent figure in the realm of oligonucleotide manufacturing, with a patented process that showcases his inventive spirit. His contributions to the industry are noteworthy and continue to influence advancements in biotechnology.